< Back to Newsletter Archive

BIO Urges Governor Pence to Sign Bill That Ensures Patient Access to Interchangeable Biologic Medicines | BIOtechNow
Add [email protected] to your contacts to ensure email delivery. Not displaying correctly? View this email in a browser. If you received this message from a friend, please subscribe to BIO Newsletter.
Visit bio.org | Read our blogs at biotech-now.org
Governor Pence

INTERCHANGEABLE BIOLOGICS

BIO Urges Governor Pence to Sign Bill That Ensures Patient Access to Interchangeable Biologic Medicines

BIO and the Indiana Health Industry Forum (IHIF) call upon Governor Pence to sign critical legislation to create a pathway for the substitution of interchangeable biologic medicines. This bill enjoys the support of a broad coalition of biologic and biosimilar manufacturing companies and includes transparent communication on all biologic medicines dispensed in order to maintain a consistent and complete medical record...

FARM BILL

Why the Farm Bill is a Big Win for Biofuels

BIO's Brent Erickson, executive vice president of the industrial & environmental section, wrote a noteworthy op-ed titled “Some Good News for a Change: Why The Farm Bill Is a Big Win for Biofuels and Biorefineries.”

2014 BIO CEO & INVESTOR CONFERENCE

U.S. Rep. Charlie Dent Discusses PDUFA and NIH Funding at #BIOCEO14

During the 16th Annual BIO CEO & Investor Conference, U.S. Representative Charlie Dent of Pennsylvania, co- chair of the Congressional Biomedical Research Caucus, joined BIO’s Fritz Bittenbender to discuss the biotech industry in Pennsylvania...

HEALTH

Biotechnology Mending Broken Hearts

A new treatment using pluripotent cells could potentially repair and regenerate damaged heart tissue. In a 2013 study published in The Lancet, Dr. Eduardo Marban, director of the Cedars Sinai Heart Institute, treated 17 heart attack patients with an injection of heart cells grown from their stem cells...

2014 BIO CEO & INVESTOR CONFERENCE

#BIOCEO14: An Optimistic Outlook for 2014

The 16th Annual BIO CEO & Investor Conference​ concluded with a lively Closing Plenary Session examining the current capital market for IPOs, where the industry has been and where it’s headed in 2014...

2014 BIO CEO & INVESTOR CONFERENCE

Business Roundtable: The Reimbursement Landscape under ACA

As the Affordable Care Act is implemented, reimbursement for life-saving and life-enhancing drugs is one of the most pressing issues facing healthcare stakeholders and decision makers, including patients, payers, providers, and innovative drug developers...

VACCINES

National Health Interview Survey: Adult Vaccination Rates Need Boost

The CDC recently released immunization coverage estimates from the 2012 NHIS for six vaccines routinely recommended for adults including pneumococcal, tetanus and Tdap, Hepatitis A, Hepatitis B, herpes zoster (shingles), and Human papillomavirus...

BUSINESS AND INVESTMENTS

The Economist – Biotechnology: Fever Rising

After speaking with several attendees and speakers at last week's BIO CEO & Investor Conference, the Economist featured an article this week about the strong performance of biotech equities recently...

HEALTH

Immuno Oncology – A 30-year Overnight Success Story

A panel of distinguished speakers reminisced about the past, present and future of i-onc, bringing it from a promising hypothesis to a new modality of cancer treatment of today...

FARM BILL

The 2014 Farm Bill Becomes Law at MSU

When President Obama toured the MBI facility and then signed the 2014 Farm Bill into law, he closed the circle on a more-than-two-year effort to enact this important legislation...

HEALTH

Physician Payments Sunshine Act: Collaboration Key for Doctors & Biopharmas

Discovery of new and improved medicines would be impossible without collaborations between physicians and biopharmaceutical companies. Consider ongoing research and clinical trials that not only make medicines possible, but also help our understanding of disease...

BIOTERRORISM

Bioterrorism: Assessing the Threat

Recently, the House of Representatives Homeland Security Committee Subcommittee on Emergency Preparedness, Response, and Communications held a hearing on bioterrorism and biological warfare...

HEALTH

Partnership for Part D Access Launches Today

BIO joins patient groups and other health care stakeholders today to announce the formation of the Partnership for Part D Access, a coalition committed to protecting access to necessary medications for patients in the Medicare Part D prescription drug program...

FOOD AND AGRICULTURE

Contrary to Reuters Coverage, Benefits of GE Crops Highlighted in USDA Report

Farmer adoption of genetically engineered (GE) crops is associated with time savings, lower insecticide use, and more conservation tillage, according to a new USDA study...

INTELLECTUAL PROPERTY

Special 301: BIO Highlights Challenges in India

BIO recently testified before the U.S. government on the intellectual property challenges our members face in various markets around the world...

FOOD AND AGRICULTURE

GMO Answers Piece "Random Thoughts etc"

The Lowdown on GMOs: According to Science, compiled by Fourat Janabi, features contributions by public scientists, authors, farmers, science writers and journalists who answer the hard questions surrounding GMOs...
ADVERTISEMENT
Conferences & Events
Conferences & Events

04.08.14

BIO Asia International Conference

The BIO Asia International Conference is an exclusive, customized partnering forum that brings together U.S. and European drug development companies with Asian biotech and pharmaceutical companies...

REGISTER

04.08.14

Legislative Day Fly-In 2014

Once a year, BIO hosts the Legislative Day Fly-In, inviting biotechnology executives from across the country to come to Washington D.C. for a day and a half of legislative briefings and advocacy...

REGISTER

04.23.14

BIO IP Counsels Committee Conference

Over the past nine years, BIO's semiannual IP Counsels Committee Conference has become a popular and growing event among our members' IP and legal professionals...

REGISTER

05.12.14

World Congress on Industrial Biotechnology

The BIO World Congress on Industrial Biotechnology is the world's largest industrial biotechnology event for business leaders, investors, and policy makers in biofuels, biobased products, and renewable chemicals...

REGISTER

06.21.14

BIO Executive Training Programs

The Business Development Basics and Advanced Business Development courses support the activity that takes place at our partnering, investor and venture capital conferences each year by training individuals who are making the deals that drive this industry...

REGISTER

06.23.14

BIO International Convention

The largest, most influential biotech meeting in the world is coming to San Diego, June 23 – 26, 2014, offering four days of career-boosting opportunities—from targeted education sessions and specialty forums to BIO One-on-One Partnering™ meetings with thousands of companies. Join the global biotech community at BIO 2014...

REGISTER

09.16.14

Livestock Biotech Summit

This unique conference offers a focus on genetic engineering of agricultural animals including benefits, research and development, regulatory system, and challenges to advancing health, food and industrial applications of animal biotechnology...

SAVE THE DATE

Bio Jobs - The talent hub for biotech

Regulatory Affairs Sr Manager - CMC and Biosimilars, Amgen

Thousand Oaks, California, United States
Feb 3, 2014

Discovery Program Leader, Safety Assessment, Merck & Company Inc.

Boston, Massachusetts, United States
Feb 19, 2014

Clinical Molecular Laboratory Supervisor, Cancer Genetics, Inc.

Rutherford, New Jersey, United States
Jan 30, 2014

Vice President Corporate Development, GlycoMimetics, Inc.

Gaithersburg, Maryland, United States
Feb 5, 2014

Principal Investigator Scientific Project Manager, Bio-analysis, HPLC, LC-MS, Quantitation

Indianapolis, Indiana, United States
Feb 5, 2014

POST A BIOTECHNOLOGY JOB >

ON FACEBOOK.COM/IAMBIOTECH
No, GMOs Won’t Harm Your Health...
11 SHARES | JOIN
ON TWITTER.COM/IAMBIOTECH
Apparently #biotech is booming! 2 headlines in major papers. Here's one more: Biotech booms on Wall Street... ow.ly/tXQIW
46 CLICKS | JOIN
ON LINKEDIN.COM/IAMBIOTECH
Sleep and Cardiovascular diseases
Prolonged Wakefulness: Lack of Sufficient Duration of Sleep as a Risk Factor for Cardiovascular Diseases - Indications for Cardiovascular Chrono-therapeutics...
5 COMMENTS | JOIN
Visit bio.org | Read our blogs at biotech-now.org